Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, Jeremie Calais, Amir Iravani, Heather Jacene, Phillip J Koo, Alicia K Morgans, Joseph R Osborne, Scott T Tagawa, Mary-Ellen Taplin, Oliver Sartor, Michael J Morris
{"title":"SNMMI关于患者选择和适当使用177Lu-PSMA-617放射性核素治疗的共识声明。","authors":"Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, Jeremie Calais, Amir Iravani, Heather Jacene, Phillip J Koo, Alicia K Morgans, Joseph R Osborne, Scott T Tagawa, Mary-Ellen Taplin, Oliver Sartor, Michael J Morris","doi":"10.2967/jnumed.123.265952","DOIUrl":null,"url":null,"abstract":"Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Radiology, University of Washington, Seattle, Washington; Department of Radiology, Brigham and Women’s Hospital, and Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts; Banner M.D. Anderson Cancer Center, Phoenix, Arizona; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; Mayo Clinic, Rochester, Minnesota; and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York","PeriodicalId":16758,"journal":{"name":"Journal of Nuclear Medicine","volume":null,"pages":null},"PeriodicalIF":9.1000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.\",\"authors\":\"Thomas A Hope, Emmanuel S Antonarakis, Lisa Bodei, Jeremie Calais, Amir Iravani, Heather Jacene, Phillip J Koo, Alicia K Morgans, Joseph R Osborne, Scott T Tagawa, Mary-Ellen Taplin, Oliver Sartor, Michael J Morris\",\"doi\":\"10.2967/jnumed.123.265952\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Radiology, University of Washington, Seattle, Washington; Department of Radiology, Brigham and Women’s Hospital, and Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts; Banner M.D. Anderson Cancer Center, Phoenix, Arizona; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; Mayo Clinic, Rochester, Minnesota; and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York\",\"PeriodicalId\":16758,\"journal\":{\"name\":\"Journal of Nuclear Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":9.1000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nuclear Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2967/jnumed.123.265952\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2967/jnumed.123.265952","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy.
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Radiology, University of Washington, Seattle, Washington; Department of Radiology, Brigham and Women’s Hospital, and Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts; Banner M.D. Anderson Cancer Center, Phoenix, Arizona; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; Mayo Clinic, Rochester, Minnesota; and Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York
期刊介绍:
The Journal of Nuclear Medicine (JNM), self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), provides readers worldwide with clinical and basic science investigations, continuing education articles, reviews, employment opportunities, and updates on practice and research. In the 2022 Journal Citation Reports (released in June 2023), JNM ranked sixth in impact among 203 medical journals worldwide in the radiology, nuclear medicine, and medical imaging category.